Fabrication of a decellularized liver matrix–based hepatic patch for the repair of CCl4‐induced liver injury
Biotechnology Journal · 2024
DOI: 10.1002/biot.202300570 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von Ting-Yi Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomechatronics Engineering, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Carbon Tetrachloride, Liver, Hepatocyte Growth Factor, Heparin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Taiwan University Hospital and National Taiwan University, National Taiwan University.
Abstract (Originalsprache)
This article primarily introduces a new treatment for liver fibrosis/cirrhosis. We developed a hepatic patch by combining decellularized liver matrix (DLM) with the hepatocyte growth factor (HGF)/heparin–complex and evaluated its restorative efficacy. In vitro prophylactic results, the HGF/heparin–DLM patches effectively mitigated CCl 4 ‐induced hepatocyte toxicity and restored the cytotoxicity levels to the baseline levels by day 5. Furthermore, these patches restored albumin synthesis of injured hepatocytes to more than 70% of the normal levels within 5 days. In vitro therapeutic results, the urea synthesis of the injured hepatocytes reached 91% of the normal levels after 10 days of culture, indicating successful restoration of hepatic function by the HGF/heparin–DLM patches in both prophylactic and therapeutic models. In vivo results, HGF/heparin–DLM patches attached to the liver and gut exhibited a significant decrease in collagen content (4.44 times and 2.77 times, respectively) and an increase in glycogen content (1.19 times and 1.12 times, respectively) compared to the fibrosis group after 1 week, separately. In summary, liver function was restored and inflammation was inhibited through the combined effects of DLM and the HGF/heparin–complex in fibrotic liver. The newly designed hepatic patch holds promise for both in vitro and in vivo regeneration therapy and preventive health care for liver tissue engineering.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomechatronics Engineering, National Taiwan University, Taipei, Taiwan.
ORCID-Profile: Yung-Te Hou
Förderung
- National Taiwan University Hospital and National Taiwan University
- National Taiwan University
Zitieren
APA
Wu, T. Y., Hsieh, Y. C., Yin, W. R., Cheng, K. Y., & Hou, Y. T. (2024). Fabrication of a decellularized liver matrix–based hepatic patch for the repair of CCl4‐induced liver injury. Biotechnology Journal. https://doi.org/10.1002/biot.202300570
Vancouver
Wu TY, Hsieh YC, Yin WR, Cheng KY, Hou YT. Fabrication of a decellularized liver matrix–based hepatic patch for the repair of CCl4‐induced liver injury. Biotechnology Journal. 2024. doi:10.1002/biot.202300570
BibTeX
@article{Wu2024,
author = {Wu, Ting-Yi and Hsieh, Yi-Cheng and Yin, Wei-Rong and Cheng, Kai-Yi and Hou, Yung-Te},
title = {Fabrication of a decellularized liver matrix–based hepatic patch for the repair of CCl4‐induced liver injury},
journal = {Biotechnology Journal},
year = {2024},
doi = {10.1002/biot.202300570}
}
EUVIMED